Synovial Sarcoma, X Breakpoint 6 (Pseudogene) (SSX6) Peptid
SSX6
Reaktivität: Säugetier
Wirt: Synthetic
BP, WB, IHC
Produktnummer ABIN939479
Kurzübersicht für Synovial Sarcoma, X Breakpoint 6 (Pseudogene) (SSX6) Peptid (ABIN939479)
Target
SSX6
(Synovial Sarcoma, X Breakpoint 6 (Pseudogene) (SSX6))
Spezies
Säugetier
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Protein-Typ
- Synthetic
-
Sequenz
- IPKIMPEKPA EEGSDSKGVP EASGPQNDGK KLCPPGKASS SEKIHERSGP
-
Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of SSX6 antibody,
Alternative Names: SSX6 control peptide, SSX6 antibody Blocking Peptide, Anti-SSX6 Blocking Peptide, synovial sarcoma, X breakpoint 6 Blocking Peptide, dJ54B20.1 Blocking Peptide, SSX6, SSX-6, SSX 6, SSX-6 Blocking Peptide, SSX 6 Blocking Peptide
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20 °C long term.
-
-
- SSX6 (Synovial Sarcoma, X Breakpoint 6 (Pseudogene) (SSX6))
-
Hintergrund
- SSX6 belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy.
-
Molekulargewicht
- 22 kDa
Target
-
Sie sind hier:
